Treatment Prior to Injection and Biopsy of the Vulva

Sponsor
University of Missouri-Columbia (Other)
Overall Status
Terminated
CT.gov ID
NCT03444727
Collaborator
(none)
13
1
2
46.4
0.3

Study Details

Study Description

Brief Summary

This study will compare pre-treatment with ice prior to injection of local anesthetic for vulvar biopsy to no pre-treatment and evaluate pain levels and patient satisfaction with the procedure.

Condition or Disease Intervention/Treatment Phase
  • Other: Ice Pre-treatment
  • Other: Room Temperature Water Pre-treatment
N/A

Detailed Description

To diagnose skin conditions of the vulva and determine appropriate treatment, a biopsy is often taken as an outpatient procedure. Prior to biopsy, the skin is cleansed and injected with a numbing solution. These injections can be quite painful in this sensitive area.

Ice has been used as topical anesthesia in a number of sites, including the cornea, the skin, and particularly in the mouth prior to anesthetic injections. However, there is no evidence for using ice anesthesia prior to injections of the vulvar tissues.

The purpose of this study is to evaluate the efficacy of using ice as pre-treatment prior to the injection of local anesthetic for vulvar biopsy.

Study Design

Study Type:
Interventional
Actual Enrollment :
13 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Participants will be randomly assigned to either pre-treatment with ice inside a sterile glove or with room-temperature water inside an exam glove.Participants will be randomly assigned to either pre-treatment with ice inside a sterile glove or with room-temperature water inside an exam glove.
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Treatment Prior to Injection and Biopsy of the Vulva
Actual Study Start Date :
Feb 19, 2018
Actual Primary Completion Date :
Dec 31, 2021
Actual Study Completion Date :
Dec 31, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Ice Pre-treatment

Participants will hold an exam glove filled with ice to intended biopsy area for 30 seconds prior to preparation and local anesthetic injection.

Other: Ice Pre-treatment
Topical application of ice prior to local anesthetic injection.

Placebo Comparator: Room Temperature Water Pre-Treatment

Participants will hold an exam glove filled with room temperature water to intended biopsy area for 30 seconds prior to preparation and local anesthetic injection.

Other: Room Temperature Water Pre-treatment
Topical application of room-temperature water prior to local anesthetic injection.

Outcome Measures

Primary Outcome Measures

  1. Post-injection Pain Score [Immediately after local anesthetic injection]

    Patient's self-reported visual analogue pain scale (100 millimeter) after injection of local anesthetic. Range from 0 to 100 mm, with 0 being least amount of pain and 100 being the most amount of pain.

Secondary Outcome Measures

  1. Post-procedure satisfaction score [Immediately after procedure]

    Patient's self-reported visual analogue scale (100 millimeter) for satisfaction with the procedure. Range form 0mm to 100mm with 0 being the least satisfied and 100 being the most satisfied.

  2. Post-procedure anxiety score [Immediately after procedure]

    Patient's self-reported visual analogue scale (100 millimeter) score for anxiety level about having another vulvar biopsy in the future. Range from 0mm to 100mm, with 0 being the least anxious and 100 being the most anxious about a future procedure.

  3. Post-procedure pain control score [Immediately after procedure]

    Patient's self-reported visual analogue scale (100 millimeter) for satisfaction with pain control during procedure. Range from 0mm to 100mm with 0 being the least satisfied with pain control and 100mm being the most satisfied with pain control.

  4. Post-biopsy pain score [Immediately after procedure.]

    Patient's self-reports visual analogue pain scale (100 millimeter) score immediately after biopsy. Range from 0mm to 100mm, with 0 being the the least pain and 100 being the most pain.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Female

  • 18 years of age or older

  • Undergoing vulva biopsy during clinic visit

  • Willing and able to comply with study protocol

  • Able to understand and provide informed consent

Exclusion Criteria:
  • Inability to provide informed consent

Contacts and Locations

Locations

Site City State Country Postal Code
1 Missouri Ob/Gyn Associated Columbia Missouri United States 65202

Sponsors and Collaborators

  • University of Missouri-Columbia

Investigators

  • Principal Investigator: Courtney Barnes, MD, University of Missouri-Columbia

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Kirby Woodall, Resident Physician, University of Missouri-Columbia
ClinicalTrials.gov Identifier:
NCT03444727
Other Study ID Numbers:
  • 2010101
First Posted:
Feb 23, 2018
Last Update Posted:
Apr 6, 2022
Last Verified:
Mar 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Kirby Woodall, Resident Physician, University of Missouri-Columbia
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 6, 2022